The global surgical tourniquet market is estimated to be worth USD 545.1 million by 2024 and is projected to reach a value of USD 905.1 million by 2034, growing at a CAGR of 5.2% from 2024 to 2034.
The industry is slated for robust growth during the forecast period, ushered by the pervasiveness of orthopedic surgeries, an upsurge in trauma cases, and developments in surgical procedures.
The advancing prevalence of bone-related illnesses, like fractures and osteoarthritis, entails numerous orthopedic surgeries. The surgical tourniquets are vital in such procedures to control blood flow and produce a bloodless surgical field, enhancing the accuracy of surgical interventions.
The prevalence of road accidents and sports injuries assists considerably in the demand for surgical tourniquets. Emergency and trauma care need the adoption of surgical tourniquets to govern severe bleeding, which is life-saving in dangerous conditions.
Rising developments, like the innovation of electronic and automated tourniquets, improve their efficacy and security. These modern systems present better pressure control and monitoring, curbing the risk of intricacies like nerve damage and ischemia.
| Attributes | Description |
|---|---|
| Historical Size, 2023 | USD 514.8 million |
| Estimated Global Surgical Tourniquet Market Size (2024E) | USD 545.1 million |
| Projected Global Surgical Tourniquet Market Value (2034F) | USD 905.1 million |
| Value-based CAGR (2024 to 2034) | 5.2% |
The cognizance of the significance of hemorrhage control and the application of training schemes for emergency healthcare services and military professionals surges the sales. Proper adoption of this devices in pre-hospital settings remarkably enhances patient outcomes.
North America takes precedence in the healthcare sector owing to numerous surgical processes, advanced healthcare facilities, and considerable investments in medical care research and development.
Europe follows after North America, with significant growth bolstered by spurring healthcare expenses and the intensifying adoption of progressive surgical technologies. Asia Pacific experiences a considerable growth rate, characterized by the population base, booming healthcare consciousness, and advancing healthcare infrastructure.
The industry features several vendors, like Zimmer Biomet, Stryker Corporation, and Delfi Medical Innovations. The manufacturers concentrate on innovation, partnerships, and mergers and acquisitions to stimulate the industry positions.
The ecosystem is likely to witness strong growth, directed by the soaring numerous surgeries and trauma cases, technical advances, and enhanced healthcare cognizance. With continuous advancements and intensifying adoption, the surgical tourniquet market outlook is optimistic.
Military professionals have used tourniquets extensively in the Middle East. Throughout history, tourniquets have been consistently cited as an effective and safe way to control severe bleeding from extremities during war and conflict. Developing improved tourniquets and protocols has been made easier with insights gained from military applications.
The effectiveness of tourniquets has been enhanced by a variety of commercial designs. Several studies have demonstrated that different tourniquet designs are reliable, efficient, and durable.
Combat Application Tourniquets (CAT) were found to be as effective and more convenient than other tourniquets, a study indicated. Commercial tourniquet designs aim to improve bleeding control and efficiency, and to provide a better tourniquet that can be used more reliably and efficiently.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The table presents the projected CAGRs for several semi-annual periods between 2024 and 2034 for the surgical tourniquet market. The growth rate of the business is expected to reach 5.9% in the first half (H1) of the decade of 2023 to 2033, followed by a slightly lower 5.6% in the second half (H2).
| Particular | Value CAGR |
|---|---|
| H1 | 5.9% (2023 to 2033) |
| H2 | 5.6% (2023 to 2033) |
| H1 | 5.5% (2024 to 2034) |
| H2 | 5.1% (2024 to 2034) |
Throughout the subsequent period, between H1 2024 and H2 2034, the CAGR is expected to decrease slightly to 5.5% in the first half and hold 5.1% in the second half.
Modern Technologies and Regulatory Approvals to Drive Growth
A number of public health initiatives have emphasized the importance of controlling bleeding during accidents and trauma in order to reduce mortality and morbidity. As obesity and its associated bariatric surgery prevalence increases, tourniquets are being used to manage blood flow during bariatric surgeries.
In addition to government funding and the development of healthcare infrastructures, the industry is also benefitting from the expansion of healthcare infrastructure.
In clinical settings, tourniquets are approved by regulatory agencies and certified for effectiveness and safety. As tourniquets become more accepted and approved, the industry is expected to grow. The introduction of modern technologies, such as Bluetooth-enabled tourniquets, can also be credited with making the industry more advanced.
Increasing demand for patient-specific tourniquet solutions, which are tailored to individual requirements and needs, is increasing due to their success in improving outcomes.
An increase in postoperative rehabilitation outcomes is associated with the use of tourniquets, particularly in orthopedic and limb surgery. As a result of these positive correlations, their use is increased.
Advanced Trauma Care to Provide Lucrative Opportunities
In recent years, advances in biomedical engineering have improved the ability to customize tourniquet systems according to surgeons and procedures, improving safety and efficiency.
A number of advancements in tourniquet technology have produced improved cuffs capable of creating a safe, low-pressure gradient on the underlying patient limbs, as well as systems capable of applying pressure automatically for a short period of time.
The popularity of aesthetic procedures and best-in-class trauma care drive demand in the market. Through the use of surgery tourniquets, surgeons can minimize perioperative blood loss and optimize antibiotic delivery.
A number of new tourniquet inflation devices, such as S-MART, aim to improve patient safety and reduce complications associated with tourniquet use. Trials and studies with a larger sample size will be conducted in order to prove the efficacy of these products.
Surgical Tourniquets Demand Side Trends
The healthcare industry is evolving, directed by catalysts like population growth, aging population, and innovation in medical technology. Within the industry, the demand for surgical tourniquets upswing as surgical processes become pervasive.
Adherence to regulatory standards is essential in the medical device sector. The vendors should be informed about shifts in rules and standards to warrant that products satisfy the essential needs of new entrants.
Training medical care professionals regarding the advantages and proper adoption of operative tourniquets is vital. The manufacturers can create learning materials or training projects to ensure that users comprehend the best activities and health precautions.
Tourniquet adoption during extremities surgery became widespread in orthopedics, as per a paper published in July 2022 in the Journal of Experimental Orthopedics. Around 90% of surgeons in the United States and the United Kingdom are thought to use tourniquets when doing total knee arthroplasty regularly.
Factors Adversely Affecting Surgical Tourniquet Industry Size Expansion
Economic fluctuations in medical care expenditure impede the growth for the market. The industry players should be prepared to traverse through periods of economic unreliability and modify their strategies correspondingly.
Adherence to strict regulatory standards and shifting guidelines are challenging for vendors functioning in the sector. Compliance with the regulations needs considerable investments in research, development, and quality control procedures.
As with any medical equipment, there are inherent threats related to the implementation of tourniquets in surgeries. The producers invest in extensive liability insurance and administer rigorous quality assurance standards to curb the hazard of product-related occurrences and legal actions.
Principal Consultant
The global surgical tourniquet market reached USD 381.4 million in 2019. Subsequently, demand for surgical tourniquets exhibited an HCAGR of 6.2% and acquired USD 514.8 million in 2023.
The industry has witnessed notable growth from 2019 to 2023, ushered by factors like a spur in surgical processes, improvement in medical technology, and surging consciousness regarding patient safety. This period experienced an upsurge in demand, with prominent vendors launching novel products to satisfy the developing requirements of healthcare providers.
Between 2024 and 2034, the demand for surgical tourniquets is on an upward trajectory. Catalysts aiding this growth are the pervasiveness of chronic disorders compelling surgical interventions, proliferating healthcare institutions in developing countries, and an aging population needing surgical interventions.
Developments in surgical procedures and a pressing focus on patient safety augment the adoption of these devices. The soaring investments in healthcare research and development and the launch of advanced tourniquet systems stimulate the growth during the forecast period.
The industry is slated for considerable growth between 2024 and 2034, proffering lucrative opportunities for providers to cash on the evolving demand.
A significant 28.7% share of the global market has been captured by companies in the Tier 1 category. Tourniquets in surgical procedures are part of the product offerings of these well-established medical device companies. With their strong financial positions, distribution channels, and research and development resources, they have an edge in the market.
Their innovative capabilities and ability to meet the diverse needs of customers around the world indicate that they will remain at the forefront. Prominent players include Stryker Corporation and Zimmer Biomet.
Tier 2 companies represent a 34.2% share of the industry is higher than that of tier 1 companies, demonstrating a strong presence overseas and an in-depth understanding of the industry. Surgical tourniquet companies in Tier 2 are specialized in this area.
Quality and innovation must remain at the forefront of this niche sectors. While niche players command a relatively small share of the market, they have a larger reach and financial clout than Tier 1 players. Their specialization and targeted approach enable them to deliver excellent results. Prominent tier 2 players include VBM Medizintechnik and Delfi Medical Innovations.
Most small firms in Tier 3 are regionally dominant and specialize in a narrow range of products. Offering a broad range of surgical products that are tailored to specific customer requirements in order to offer cost-effective solutions.
Players will perform exponentially in the industry if they comply with international standards and stringent regulations. Players include Ulrich Medical, Anetic Aid, Hammarplast Medical, Daesung Maref, OHK Medical Devices, and Dessillons & Dutrillaux.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The section below covers the forecast for emerging markets for surgical tourniquets in terms of countries. Information on key countries in several parts of the globe, including North America, Asia Pacific, Europe, and others, is provided.
The United States is anticipated to remain at the forefront in North America, with a CAGR of 5.8% through 2034. In Asia Pacific region, India experiences a CAGR of 7.7% by 2034.
| Countries | CAGR 2024 to 2034 |
|---|---|
| United States | 5.8% |
| Germany | 6.2% |
| United Kingdom | 4.3% |
| India | 7.7% |
| China | 7.9% |
The United States is encouraged by modern medical care facilities and a strong demand for innovative healthcare devices. The flourishing consciousness concerning the advantages of minimally invasive surgical methods assists in the growth of the market.
The role of regulatory bodies in governing the surgical tourniquet sector market ushers the adoption of tourniquet technologies in the United States.
The pervasiveness of chronic illnesses and the inclining geriatric population ushered in the demand for the market in the United States. Technological innovations and partnerships among essential vendors advance the industry expansion in the United States.
The market in Germany thrives on a focus on accuracy and quality, indicating the impact of new technologies like artificial intelligence on the market. The strict rules and emphasis on product efficiency direct innovation and expansion in Germany's medical tourniquet market.
Germany experiences growth amplified by a strengthening number of surgeries and proliferating investments in healthcare facilities. The commitment to patient safety and high standards of healthcare delivery in Germany stimulate the growth avenue of the market.
The market in India witnessed steady growth characterized by a proliferating healthcare system and widening medical tourism. The adoption of digital health tech and telemedicine platforms augments the business in India, particularly in remote regions with constrained access to medical care amenities.
The disposable and environmental sustainability concerns catapult the use of the instruments in India. The towering investments in healthcare units and government schemes to encourage medical device production bolster the growth in the market.
The section contains information about the leading segments in the surgical tourniquet industry. In terms of product type category, the tourniquet cuffs segment garners a share of 78.4% by 2034. By application category, the knee arthroplasty segment takes precedence with a share of 33.1% in 2034.
| Segment | Tourniquet Cuffs |
|---|---|
| Value Share (2034) | 78.4% |
Tourniquet cuffs are usually cheaper as compared to complete tourniquet systems, making them widely available and easier to purchase. They are replaced frequently because of wear and hygiene rules, spurring significant sales.
Hospitals and surgical centers prioritize storing tourniquet cuffs because of their vital role and standard demand in surgeries. Cuffs are used with diverse tourniquet systems, improving their flexibility and demand. As the number of surgeries escalates, the demand for tourniquet cuffs also rises, resulting in a steady boom in sales.
| Segment | Joint Replacement |
|---|---|
| Value Share (2034) | 33.1% |
A tourniquet is a widely accepted and effective practice during knee replacement surgery. In addition to preventing blood loss, it improves the visibility of the wound and stops the bleeding. The use of tourniquets during joint arthroplasty surgery further prevents bleeding from resurfaced bones, so bone-implant cementation can proceed more successfully.
Tourniquets may improve the long-term survival of knee implants by reducing bleeding from porous bone ends, thereby improving the bond between the soft cement and the bone. The tourniquet can reduce the frequency of suctioning and reduce complication risk during surgery.
Key surgical tourniquet vendors use promotional and distribution procedures, like direct sales to medical care experts and sales to public health facilities. To keep up with demand globally, surgical tourniquet providers are strengthening their manufacturing capacity.
The majority of the leading producers are not only meeting the demand but also innovating. They are focusing on locating and making advantageous technologies and targeted products from internal as well as external sources.
This active approach is targeted at satisfying the unsatisfied demand in emerging economies, sustaining a positive sense of the industry's future. The manufacturers adopt partnerships and acquisitions as their primary strategies to intensify sales across regions.
Investment Analysis of Specific Surgical Tourniquet Companies
| Company | Stryker Corporation |
|---|---|
| Headquarter | United States |
| Recent Advancement | In February 2022, Stryker announced the acquisition of Vocera Communications, Inc. which is a pioneer in digital care collaboration and communication. |
| Company | Zimmer Biomet |
|---|---|
| Headquarter | United States |
| Recent Advancement | Zimmer Biomet Holdings, Inc. announced the acquisition of Embody, Inc. in January 2023, which is focused on soft tissue healing, for USD 155 million at closing and an additional USD 120 million determined to achieve regulatory and commercial milestones over three years. The acquisition is cumulative to the revenue growth and moderately dilutive to earnings per share. |
| Company | Ulrich GmbH & Co.KG |
|---|---|
| Headquarter | Germany |
| Recent Advancement | Bracco and Ulrich GmbH Co KG, a popular medical device producer specializing in media injectors and spinal implants, announced a long-term partnership in November 2023 that brings a Bracco-branded modern MR injector to the United States. |
The industry is bifurcated into tourniquet systems and tourniquet cuffs. The tourniquet systems category is further bifurcated into single channel systems and dual channel systems.
The tourniquet cuffs category is further bifurcated into inflatable cuffs and non-inflatable cuffs. The inflatable cuffs sub-segment in further bifurcated into disposable cuffs and reusable cuffs. The non-inflatable cuffs sub-segment in further bifurcated into disposable cuffs and reusable cuffs
The application category is classified into knee arthroplasty, amputation of limbs, plastic surgeries, and trauma cases.
The end user category is trifurcated into hospitals, ambulatory surgical centers, and specialized clinics.
The surgical tourniquet industry to acquire a valuation USD 545.1 million in 2024.
The surgical tourniquet sector is likely to be worth USD 905.1 million by 2034.
The surgical tourniquet ecosystem infers a CAGR of 5.2% through 2034.
From 2019 to 2023, the surgical tourniquet market exhibited an 6.2% CAGR.
The tourniquet cuffs sector garnered a share of 78.4% in 2023.
The Joint Replacement sector possessed a share of 33.1% in 2023.
1. Executive Summary 2. Industry Introduction, including Taxonomy and Market Definition 3. Market Trends and Success Factors, including Macro-economic Factors, Market Dynamics, and Recent Industry Developments 4. Global Market Demand Analysis 2019 to 2023 and Forecast 2024 to 2034, including Historical Analysis and Future Projections 5. Pricing Analysis 6. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034 6.1. Product 6.2. Application 6.3. End-User 7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Product 7.1. Tourniquet Systems 7.1.1. Single Channel Systems 7.1.2. Dual Channel Systems 7.2. Tourniquet Cuffs 7.2.1. Inflatable Cuffs 7.2.1.1. Disposable Cuffs 7.2.1.2. Reusable Cuffs 7.2.2. Non-Inflatable Cuffs 7.2.2.1. Disposable Cuffs 7.2.2.2. Reusable Cuffs 8. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Application 8.1. Knee Arthroplasty 8.2. Amputation of Limbs 8.3. Plastic Surgeries 8.4. Trauma Cases 8.5. Joint Replacement 9. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By End-User 9.1. Hospitals 9.2. Ambulatory Surgical Centers 9.3. Specialized Clinics 10. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Region 10.1. North America 10.2. Latin America 10.3. Western Europe 10.4. South Asia 10.5. East Asia 10.6. Eastern Europe 10.7. Middle East & Africa 11. North America Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 12. Latin America Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 13. Western Europe Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 14. South Asia Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 15. East Asia Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 16. Eastern Europe Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 17. Middle East & Africa Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 18. Sales Forecast 2024 to 2034 by Product, Application, and End-User for 30 Countries 19. Competition Outlook, including Market Structure Analysis, Company Share Analysis by Key Players, and Competition Dashboard 20. Company Profile 20.1. Stryker Corporation 20.2. Zimmer Biomet 20.3. Ulrich Medical 20.4. Hammarplast Medical 20.5. Anetic Aid 20.6. VBM Medizintechnik 20.7. Delfi Medical Innovations 20.8. Daesung Maref 20.9. OHK Medical Devices 20.10. Dessillons & Dutrillaux
Explore Healthcare Insights
View Reports
Surgical Tourniquet Market
